Beata Jurecka‐Lubieniecka

Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients

Maria Turska, Barbara Jarząb, Daria Handkiewicz-Junak et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 84 citations

Thyroid Carcinoma, Medicine, Radionuclide Therapy +9

Association of CD40 Gene Polymorphism (C-1T) with Susceptibility and Phenotype of Graves' Disease

Alina Kuryłowicz, Dorota Kula, Agata Skórka et al. · Thyroid · 2005 · 64 citations

Association of NFKB1 −94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease

Yuji Hiromatsu, Beata Jurecka‐Lubieniecka, Dorota Kula et al. · Genes and Immunity · 2007 · 44 citations

Transcriptional Regulation, Autoimmune Disease, Medicine +8

Thyroid Stimulating Hormone Receptor (TSHR) Intron 1 Variants Are Major Risk Factors for Graves' Disease in Three European Caucasian Cohorts

Rafał Płoski, Beata Jurecka‐Lubieniecka, Maria Franaszczyk et al. · PLoS ONE · 2010 · 42 citations · Full text

Association between Age at Diagnosis of Graves' Disease and Variants in Genes Involved in Immune Response

Beata Jurecka‐Lubieniecka, Dorota Kula, Aleksandra Król et al. · PLoS ONE · 2013 · 39 citations · Full text